Rare Endocrine Disorders
Disease education
Review information important to the clinical understanding of rare endocrine disorders and patient care.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
PES referral guidelines infographic
PES referral guidelines for children with suspected short stature
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Manuscript describing the development of a novel algorithm to categorize people by their likelihood of having AGHD
Emphasis of Exposure and Training in Neurology Residency Programs to Traumatic Brain Injury-Induced Growth Hormone Deficiency: Results of a Cross-Sectional Study
This poster presents results from an online curriculum survey that was conducted among neurology residency program directors in the US to identify exposure and training to traumatic brain injury-induced growth hormone deficiency.
Adult Growth Hormone Deficiency (AGHD) Algorithm Infographic
Development story for an algorithm designed to categorize people by their likelihood to have AGHD.
Find more information
Find product information
Explore our portfolio of products for treating rare endocrine disorders, including prescribing information, safety data sheets, and storage and stability information.
Continuing education
Explore accredited rare endocrine disorders education opportunities supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
